Cost-effectiveness of lenalidomide in the treatment of patients with transfusion-dependent myelodysplastic syndromes (MDS) in the United States.

被引：0
|
作者：
Goss, TF
Szende, A
Brueckner, J
Wang, M
Schaefer, C
List, AF
机构：
[1] Covance Mkt Access Serv, Gaithersburg, MD USA
[2] Covance Mkt Access Serv, Leeds, W Yorkshire, England
[3] Celgene Corp, Pharmacoecon, Summit, NJ USA
[4] Univ S Florida, Moffit Canc Ctr & Res Inst, Tampa, FL USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1338
引用
收藏
页码：388A / 389A
页数：2
相关论文
共 50 条
  • [31] COST CHANGES ASSOCIATED WITH ACHIEVING TRANSFUSION INDEPENDENCE (TI) IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    DeZern, A. E.
    Binder, G.
    Rizvi, S.
    Corvino, F. A.
    Arikian, S. R.
    Surinach, A.
    Lee, J.
    Smith, B. D.
    HAEMATOLOGICA, 2016, 101 : 500 - 500
  • [32] Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes
    Garcia-Manero, Guillermo
    Diez-Campelo, Maria
    Vellenga, Edo
    Jacoby, Meagan A.
    Merchan, Brayan
    Breems, Dimitri
    Cortelezzi, Agostino
    Doronin, Vadim
    Gomez, Valle
    Beckers, Marielle
    Della Porta, Matteo Giovanni
    Varsos, Helen
    Xiu, Liang
    DeAngelis, Nikki
    Nnane, Ivo
    Rose, Esther
    van Eygen, Koen
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (04) : E111 - E114
  • [33] Cost-effectiveness of zanubrutinib versus ibrutinib in adult patients with Waldenstrom macroglobulinemia in the United States.
    Castillo, Jorge J.
    Yang, Keri
    Liu, Rongzhe
    Wang, Yu
    Cohen, Aileen
    Zimmerman, Todd M.
    Zhao, Qian
    van de Wetering, Gijs
    Gao, Xin
    Tang, Boxiong
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [34] Cost-effectiveness of transfusion of platelet components prepared with pathogen inactivation treatment in the United States
    Bell, CF
    Botteman, MF
    Gao, X
    Weissfeld, JL
    Postma, MJ
    Pashos, CL
    Triulzi, D
    Staginnus, U
    CLINICAL THERAPEUTICS, 2003, 25 (09) : 2464 - 2486
  • [35] Prophylactic RhCE and Kell antigen matching: impact on alloimmunization in transfusion-dependent patients with myelodysplastic syndromes
    Lin, Y.
    Saskin, A.
    Wells, R. A.
    Lenis, M.
    Mamedov, A.
    Callum, J.
    Buckstein, R.
    VOX SANGUINIS, 2017, 112 (01) : 79 - 86
  • [36] Lenalidomide treatment and the effects on T-cell receptor repertoire in patients with myelodysplastic syndromes (MDS)
    Momot, T.
    Koenig, J.
    Ganser, A.
    Mischak-Weissinger, E.-M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 413 - 414
  • [37] T-cell receptor repertoire in patients with myelodysplastic syndromes (MDS) receiving lenalidomide treatment
    Momot, T.
    Koenig, J.
    Ganser, A.
    Weissinger, E.-M.
    LEUKEMIA RESEARCH, 2007, 31 : S65 - S65
  • [38] COST-EFFECTIVENESS OF TREATMENT STRATEGIES FOR SEVERE HEMOPHILIA A PATIENTS IN THE UNITED STATES
    Bolous, N.
    Chen, Y.
    Wang, H.
    Devidas, M.
    Bhakta, N.
    Reiss, U.
    VALUE IN HEALTH, 2022, 25 (07) : S366 - S366
  • [39] The long-term cost-effectiveness of lamivudine for the treatment of chronic hepatitis B in the United States.
    Dickens, T
    Raasch, RH
    Saal, GB
    Yeh, YC
    HEPATOLOGY, 2000, 32 (04) : 590A - 590A
  • [40] Persistent Red Blood Cell (RBC) Transfusion Is Associated with Increased Mortality Risk in Transfusion-Dependent (TD) Patients with Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS plus )
    Buckstein, Rena
    Zhu, Nancy
    Keating, Mary-Margaret
    Leber, Brian
    Chodirker, Lisa
    Sabloff, Mitchell
    Cristou, Grace
    Leitch, Heather A.
    St Hilaire, Eve
    Finn, Nicholas
    Yee, Karen W. L.
    Elemary, Mohamed
    Banerji, Versha
    Lenis, Martha
    Kirubananthaan, Aksharh
    Liu, Fei Fei
    Tang, Derek
    Westcott, Chris
    Huang, Vicky Wei-Hsuen
    Wang, Di
    Cameron, Chris
    Morison, Jessica
    Spin, Paul
    Mamedov, Alexandre
    BLOOD, 2019, 134
12345